|
| 產(chǎn)地 | 進口、國產(chǎn) |
| 品牌 | 上海莼試 |
| 保存條件 | Store at -20 °C |
| 貨號 | CS10116 |
| 應用范圍 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 |
| CAS編號 | |
| 抗體名 | Anti-PIM1+PIM3 |
| 克隆性 | |
| 靶點 | 詳見說明書 |
| 適應物種 | 詳見說明書 |
| 形態(tài) | 詳見說明書 |
| 宿主 | 詳見說明書 |
| 亞型 | IgG |
| 標識物 | 詳見說明書 |
| 濃度 | 1mg/1ml% |
| 免疫原 | KLH conjugated synthetic peptide derived from human PIM1+PIM3 |
絲氨酸/蘇氨酸激酶蛋白PIM1+PIM3抗體說明書 英文名稱 Anti-PIM1+PIM3
中文名稱 絲氨酸/蘇氨酸激酶蛋白PIM1+PIM3抗體說明書
別 名 Oncogene PIM 1; Oncogene PIM1; PIM 1; pim 1 kinase 44 kDa isoform; Pim 1 kinase; pim 1 oncogene (proviral integration site 1); Pim 1 oncogene; PIM; PIM1; pim1 kinase 44 kDa isoform; PIM1_HUMAN; Pim2; PIM3; Proto oncogene serine/threonine protein kinase Pim 1; Proto-oncogene serine/threonine-protein kinase Pim-1; Proviral integration site 1; Proviral integration site 2; Kid 1; Kid-1; Kid1; Kinase induced by depolarization; ONCOGENE PIM 3; ONCOGENE PIM3; PIM 3; Pim 3 oncogene; PIM3; Pim3 oncogene; PIM3_HUMAN; Protein kinase Kid 1; Protein kinase Kid1; Serine/threonine kinase Pim 3; Serine/threonine kinase Pim3; Serine/threonine protein kinase Pim 3; Serine/threonine protein kinase Pim3; Serine/threonine-protein kinase Pim-3.
產(chǎn)品屬性：
濃 度 1mg/1ml
規(guī) 格 0.2ml/200μg
抗體來源 Rabbit
克隆類型 polyclonal
交叉反應 Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Rabbit, Sheep, Guinea Pig
產(chǎn)品類型 一抗
研究領域
蛋白分子量 predicted molecular weight: 45kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human PIM1+PIM3
亞 型 IgG
純化方法 affinity purified by Protein A
儲 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
絲氨酸/蘇氨酸激酶蛋白PIM1+PIM3抗體說明書 產(chǎn)品應用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 PIM1 is a member of the serine/threonine kinase PIM oncogene family. PIM1 has been implicated in lymphomagenesis, cell proliferation, apoptosis, differentiation and tumourigenesis. The PIM1 protein kinase is upregulated in prostate cancer.
The Pim family serine/threonine protein kinases were first identified in studies examining genes targeted for proviral insertion in murine leukemia virus-induced T lymphomas. Increased levels of Pim kinases predispose cells to lymphomagenesis and enhance the activity of mitogenic proteins such as p100, c-Myb, and Cdc25A. In addition, Pim kinases are also involved in modulation of synaptic strength in neurons and anti-apoptotic signaling in hematopoietic progenitor cells. Pim-3, a member of the proto-oncogene Pim family that expresses serine/threonine kinase activity, shares significant homology with Pim-1 serine/threonine protein kinases. Pim-3 may function as a mediator of synaptic plasticity in the brain and is presumably involved in the anti-apoptosis process and cell cycle progression as well as the proliferation of human hepatoma cell lines. The Pim-3 protein is widely expressed, however no expression is observed in the colon, thymus, or small intestine.
Function : Proto-oncogene with serine/threonine kinase activity involved in cell survival and cell proliferation and thus providing a selective advantage in tumorigenesis. Exerts its oncogenic activity through: the regulation of MYC transcriptional activity, the regulation of cell cycle progression and by phosphorylation and inhibition of proapoptotic proteins (BAD, MAP3K5, FOXO3). Phosphorylation of MYC leads to an increase of MYC protein stability and thereby an increase of transcriptional activity. The stabilization of MYC exerced by PIM1 might explain partly the strong synergism between these two oncogenes in tumorigenesis. Mediates survival signaling through phosphorylation of BAD, which induces release of the anti-apoptotic protein Bcl-X(L)/BCL2L1. Phosphorylation of MAP3K5, an other proapoptotic protein, by PIM1, significantly decreases MAP3K5 kinase activity and inhibits MAP3K5-mediated phosphorylation of JNK and JNK/p38MAPK subsequently reducing caspase-3 activation and cell apoptosis. Stimulates cell cycle progression at the G1-S and G2-M transitions by phosphorylation of CDC25A and CDC25C. Phosphorylation of CDKN1A, a regulator of cell cycle progression at G1, results in the relocation of CDKN1A to the cytoplasm and enhanced CDKN1A protein stability. Promote cell cycle progression and tumorigenesis by down-regulating expression of a regulator of cell cycle progression, CDKN1B, at both transcriptional and post-translational levels. Phosphorylation of CDKN1B,induces 14-3-3-proteins binding, nuclear export and proteasome-dependent degradation. May affect the structure or silencing of chromatin by phosphorylating HP1 gamma/CBX3. Acts also as a regulator of homing and migration of bone marrow cells involving functional interaction with the CXCL12-CXCR4 signaling axis.
Subunit : Isoform 2 is isolated as a monomer whereas isoform 1 complexes with other proteins. Binds to RP9. Isoform 1, but not isoform 2, binds BMX. Isoform 2 interacts with CDKN1B and FOXO3. Interacts with BAD. Interacts with PPP2CA; this interaction promotes dephosphorylation of PIM1, ubiquitination and proteasomal degradation. Interacts with HSP90, this interaction stabilizes PIM1 protein levels. Interacts (ubiquitinated form) with HSP70 and promotes its proteosomal degradation. Interacts with CDKN1A. Interacts with CDC25C. Interacts (via N-terminal 96 residues) with CDC25A. Interacts with MAP3K5. Interacts with MYC.
Tissue Specificity : Expressed primarily in cells of the hematopoietic and germline lineages. Isoform 1 and isoform 2 are both expressed in prostate cancer cell lines.
Post-translational modifications : Autophosphorylated on both serine/threonine and tyrosine residues. Phosphorylated. Interaction with PPP2CA promotes dephosphorylation.
Ubiquitinated, leading to proteasomal degradation.
Similarity : Belongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family. PIM subfamily.
Contains 1 protein kinase domain.
Database links : UniProtKB/Swiss-Prot: Q86V86.3 UniProtKB/Swiss-Prot: P11309.3
實驗流程：
全、新、優(yōu)、品、好四大特點：
絲氨酸/蘇氨酸激酶蛋白PIM1+PIM3抗體說明書 全：公司提供上萬種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標準品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細胞等，基本上各種科研所需產(chǎn)品在我司都能找到。
新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。
優(yōu)：產(chǎn)品質量好，投訴比較少。
好：我公司具有優(yōu)質的技術團隊，產(chǎn)品一旦售出，實驗過程中遇到困難可提供在線技術咨詢。使您使用產(chǎn)品時沒有任何的后顧之憂。
正在熱銷的相關產(chǎn)品：
OTR(oxytocin receptor) 縮宮素受體Multi-class antibodies規(guī)格： 0.5mg
Anti-Beta-arrestin 2 β-抑制蛋白2抗體Multi-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh phospho-ASK1 (Ser966) 磷酸化細胞凋亡信號調節(jié)激酶1抗體 規(guī)格 0.1ml
Troponin T 濃縮液 0.1ml 進口分裝
ULBP2 英文名稱： UL16結合蛋白2抗體 0.2ml
DHPS1 英文名稱： 短鏈脫氫還原酶1抗體 0.2ml
Anti-Beta-arrestin 2 β-抑制蛋白2抗體Multi-class antibodies規(guī)格： 0.2ml
DISC1(disrupted in schizophrenia1)(CT) DISC1 C端抗原Multi-class antibodies規(guī)格： 0.5mg
Anti-CCR7/CD197 細胞表面趨化因子受體7抗體Multi-class antibodies規(guī)格： 0.1ml
Rhesus antibody Rh Paxillin 樁蛋白Paxillin抗體 規(guī)格 0.1ml
FCGR2B Kit Human 人 CD32b / FCGR2B ELISA配對抗體 ELISA
Transaldolase 1 英文名稱： 轉醛醇酶抗體 0.2ml
CSP 英文名稱： 環(huán)子孢子蛋白(約氏)抗體 1ml
Anti-CCR7/CD197 細胞表面趨化因子受體7抗體Multi-class antibodies規(guī)格： 0.1ml
CT ELISA Kit 大鼠降鈣素Multi-class antibodies規(guī)格： 48T
Anti-ATF3/FITC 熒光素標記活化轉錄因子3抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh FADD Fas死亡結構域相關蛋白 規(guī)格 0.1ml
CDT ELISA Kit 大鼠糖缺失性轉鐵蛋白 96T
1-Mar 英文名稱： 膜相關環(huán)指蛋白1抗體 0.2ml
alpha 1 Fetoprotein 英文名稱： 甲胎蛋白抗體 0.1ml
Anti-ATF3/FITC 熒光素標記活化轉錄因子3抗體IgGMulti-class antibodies規(guī)格： 0.2ml
GRN Protein Mouse 重組小鼠 Granulin / GRN / Progranulin 蛋白 (His 標簽)
MSTO-211H 人細胞株
CD40 Others Mouse 小鼠 CD40 / TNFRSF5 人細胞裂解液 (陽性對照)
NCI-H1299人非小細胞細胞 NCI-H1299 cells in human non small cell lung cancer RPMI-1640(GIBCO)+10%FBS
人卵巢腺癌細胞;SK-OV-3
人胚肺二倍體細胞;KMB-17 人甲狀腺濾泡上皮細胞完全培養(yǎng)基 100mL
CL-0253A-427(人細胞)5×106cells/瓶×2
PGF Others Mouse 小鼠 PIGF / PLGF 人細胞裂解液 (陽性對照)
人膀胱平滑肌細胞cDNAHBdSMC cDNA
SK-BR-3細胞，人癌細胞 草魚腎細胞系,GIK細胞 肺大平滑肌細胞Many types of cells包裝：5 × 105次方(1ml)
WL1(大鼠肺細胞) 5×106cells/瓶×2
NHDF Pellet 正常人皮膚成纖維細胞團塊(少年者) > 1 mio.cells 硝基苯磷酸(pNPP)磷酸酶檢測試劑盒pNPP
絲氨酸/蘇氨酸激酶蛋白PIM1+PIM3抗體說明書 GRN Protein Mouse 重組小鼠 Granulin / GRN / Progranulin 蛋白 (His 標簽)
MSTO-211H 人細胞株
CD40 Others Mouse 小鼠 CD40 / TNFRSF5 人細胞裂解液 (陽性對照)
NCI-H1299人非小細胞細胞 NCI-H1299 cells in human non small cell lung cancer RPMI-1640(GIBCO)+10%FBS
人卵巢腺癌細胞;SK-OV-3
人胚肺二倍體細胞;KMB-17 人甲狀腺濾泡上皮細胞完全培養(yǎng)基 100mL
技術外包服務:
★絲氨酸/蘇氨酸激酶蛋白PIM1+PIM3抗體說明書 分子生物學：質粒抽提、PCR、Q-PCR、RT-PCR、分子生物學：基因合成、引物合成、基因測序、載體構建等
★蛋白工程：原核、哺乳動物蛋白表達系統(tǒng)等
★病毒包裝：腺病毒、慢病毒等
★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★細胞工程：細胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復、克隆形成)、細胞培養(yǎng)、細胞膜制備、穩(wěn)定細胞株構建、細胞RNAi技術等等。
